Vector Laboratories, Inc.

Vector Laboratories, Inc. company information, Employees & Contact Information

Vector Laboratories empowers scientific advances with innovative proteomic and glycomic solutions. Supporting scientific industries worldwide for 45 years and counting, Vector Laboratories is recognized as a pioneer and market leader in immunofluorescence, immunohistochemistry, and glycobiology products. Scientists in academic, industry, and manufacturing settings continue to rely on Vector Laboratories as a trusted partner in their quest to move science forward, with impact. Our company leadership is steadfast in its mission of empowering scientific curiosity through a culture of service, reliable products, and unmatched technical expertise; a commitment that ultimately allows scientists to make a difference in the world. As an employer, Vector Laboratories instills a work culture focused on the values of integrity, excellence, inclusion, and genuine relationship-building across employees and customers. Vector Laboratories is currently headquartered in Newark, CA. Its rich history in the development of critical and innovative scientific tools and solutions will continue as the organization grows. As the first company to commercialize avidin-biotin enzyme complex kits for immunohistochemistry and antifade mounting media for immunofluorescence, Vector Laboratories has since introduced over 600 reliable reagents and kits. Vector Laboratories products have been cited in more than 350,000 scientific publications and are included in Standard Operating Procedures in labs worldwide. Our genuine commitment to the health, well-being and work-life balance of our employers is reflected in the wide range of benefits we offer. These include competitive compensation, medical, dental, and vision plans, and a generous 401(k) retirement plan. Unique employee perks include • Free use of company condominiums in beautiful Lake Tahoe • Ticket raffle for San Francisco Giants home games (2 tickets)
Looking for a particular Vector Laboratories, Inc. employee's phone or email?

Vector Laboratories, Inc. Questions

News

RCA 1-binding glycans as a marker of Batrachochytrium salamandrivorans infection intensity at early stages of pathogenesis - Nature

RCA 1-binding glycans as a marker of Batrachochytrium salamandrivorans infection intensity at early stages of pathogenesis Nature

Antibodies come full circle: biopharma back at the bench - Drug Target Review

Antibodies come full circle: biopharma back at the bench Drug Target Review

Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy - ScienceDirect.com

Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy ScienceDirect.com

BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics - Fierce Pharma

BioDesign: Accelerating the Momentum of Bioconjugate Therapeutics Fierce Pharma

Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express - PR Newswire

Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express PR Newswire

Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers - Business Wire

Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers Business Wire

GTCR Acquires Vector Laboratories - Private Equity Professional

GTCR Acquires Vector Laboratories Private Equity Professional

ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sections - ScienceDirect.com

ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sections ScienceDirect.com

Vector Laboratories Adds Kum Ming Woo to Executive Team as Vice President, Operations - PR Newswire

Vector Laboratories Adds Kum Ming Woo to Executive Team as Vice President, Operations PR Newswire

GTCR and Maravai Complete Strategic Equity Investment in Vector Laboratories - PR Newswire

GTCR and Maravai Complete Strategic Equity Investment in Vector Laboratories PR Newswire

Top Vector Laboratories, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant